Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Glutamate and anxiety.

Bergink V, van Megen HJ, Westenberg HG.

Eur Neuropsychopharmacol. 2004 May;14(3):175-83. Review.

PMID:
15056476
2.

Glutamate receptor ligands as anxiolytics.

Chojnacka-Wójcik E, Kłodzinska A, Pilc A.

Curr Opin Investig Drugs. 2001 Aug;2(8):1112-9. Review.

PMID:
11892923
3.

Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Kew JN, Kemp JA.

Psychopharmacology (Berl). 2005 Apr;179(1):4-29. Review. Erratum in: Psychopharmacology (Berl). 2005 Oct;182(2):320.

PMID:
15731895
5.

Serotonin model of schizophrenia: emerging role of glutamate mechanisms.

Aghajanian GK, Marek GJ.

Brain Res Brain Res Rev. 2000 Mar;31(2-3):302-12. Review.

PMID:
10719157
6.

Excitatory amino acid neurotransmission.

Parsons CG, Danysz W, Zieglgänsberger W.

Handb Exp Pharmacol. 2005;(169):249-303.

PMID:
16594262
7.

Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.

Mathew SJ, Price RB, Charney DS.

Am J Med Genet C Semin Med Genet. 2008 May 15;148C(2):89-98. doi: 10.1002/ajmg.c.30172. Review.

PMID:
18412102
8.
9.

The role of glutamate in anxiety and related disorders.

Cortese BM, Phan KL.

CNS Spectr. 2005 Oct;10(10):820-30. Review.

PMID:
16400245
10.

Mood disorders: regulation by metabotropic glutamate receptors.

Pilc A, Chaki S, Nowak G, Witkin JM.

Biochem Pharmacol. 2008 Mar 1;75(5):997-1006. doi: 10.1016/j.bcp.2007.09.021. Review.

PMID:
18164691
11.

Metabotropic glutamate receptors in the control of mood disorders.

Witkin JM, Marek GJ, Johnson BG, Schoepp DD.

CNS Neurol Disord Drug Targets. 2007 Apr;6(2):87-100. Review.

PMID:
17430147
12.

Drug mechanisms in anxiety.

Bourin M, Hascoët M.

Curr Opin Investig Drugs. 2001 Feb;2(2):259-65. Review.

PMID:
11816841
13.

Are compounds acting at metabotropic glutamate receptors the answer to treating depression?

Palucha A.

Expert Opin Investig Drugs. 2006 Dec;15(12):1545-53. Review.

PMID:
17107280
14.

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.

Palucha A, Pilc A.

Pharmacol Ther. 2007 Jul;115(1):116-47. Review.

PMID:
17582504
15.

Glutamate: the new frontier in pharmacotherapy for cocaine addiction.

Uys JD, LaLumiere RT.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):482-91. Review.

PMID:
19128205
16.

Glutamate as a therapeutic target in psychiatric disorders.

Javitt DC.

Mol Psychiatry. 2004 Nov;9(11):984-97, 979. Review.

PMID:
15278097
17.

The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?

Pitsikas N.

Eur J Pharmacol. 2014 Jan 15;723:181-4. doi: 10.1016/j.ejphar.2013.12.019. Review.

PMID:
24361306
18.
19.

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.

Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD.

Nat Rev Drug Discov. 2005 Feb;4(2):131-44. Review.

PMID:
15665858
Items per page

Supplemental Content

Support Center